Portfolio Alerts Watch List Cart

Healthcare

Refine Search


Product Compare (0)
D
Dr. Lal PathLabs Ltd
Score 48/100• Decent
Dr. Lal PathLabs Ltd shows potential in a growing sector, but faces challenges in profitability and valuation metrics.
Company’s Health94/100
Valuation 20/100 · PB 11.8611
Technical Avoid
1M -0.981% 6M 12.239% 1Y 0.723%
Confidence100%
Low leverage (D/E)No promoter pledge
#286
View details ➜
D
Dr Reddy's Laboratories Ltd
Score 48/100• Decent
Dr Reddy's Laboratories shows potential with a solid business model and growth prospects, but faces challenges in profitability and market sentiment.
Company’s Health86/100
Valuation 60/100 · PB 2.9387
Technical Avoid
1M -2.26% 6M 1.243% 1Y -6.012%
Confidence100%
Low leverage (D/E)No promoter pledge
#287
View details ➜
D
Dhanvantri Jeevan Rekha Ltd
Score 48/100• Risky
Dhanvantri Jeevan Rekha Ltd shows potential in a growing sector, but inconsistent financial performance and valuation concerns warrant caution.
Company’s Health48/100
Valuation 80/100 · PB 1.1162
Technical Avoid
1M -3.2% 6M 41.487% 1Y 31.381%
Confidence100%
Low leverage (D/E)No promoter pledge
Weak ROEThin margins
#288
View details ➜
D
Deccan Health Care Ltd
Score 48/100• Risky
Deccan Health Care Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
Company’s Health54/100
Valuation 100/100 · PB 0.4175
Technical Avoid
1M -13.447% 6M -2.92% 1Y -32.213%
Confidence100%
Low leverage (D/E)No promoter pledge
Weak ROEThin margins
#289
View details ➜
C
Choksi Laboratories Ltd
Score 48/100• Risky
Choksi Laboratories Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
Company’s Health48/100
Valuation 40/100 · PB 4.229
Technical Avoid
1M -29.199% 6M 23.844% 1Y 145.883%
Confidence100%
No promoter pledgeDecent revenue growth
Weak ROEThin margins
#290
View details ➜
C
Chemo Pharma Laboratories Ltd
Score 48/100• Risky
Chemo Pharma Laboratories Ltd presents several risks with limited growth prospects and profitability concerns, making it a risky investment.
Company’s Health59/100
Valuation 80/100 · PB 1.3282
Technical Avoid
1M 6.808% 6M -11.386% 1Y 49.167%
Confidence100%
Low leverage (D/E)No promoter pledge
Weak ROE
#291
View details ➜
C
Centenial Surgical Suture Ltd
Score 48/100• Risky
Centenial Surgical Suture Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
Company’s Health39/100
Valuation 80/100 · PB 1.2814
Technical Avoid
1M 1.124% 6M -8.046% 1Y -20%
Confidence100%
No promoter pledgeReasonable PB valuation
Weak ROEThin margins
#292
View details ➜
B
Broach Lifecare Hospital Ltd
Score 48/100• Risky
Broach Lifecare Hospital Ltd shows potential in a growing sector but faces significant risks and challenges that warrant caution.
Company’s Health82/100
Valuation 80/100 · PB 1.1252
Technical Avoid
1M 0.813% 6M -13.207% 1Y -37.41%
Confidence100%
Low leverage (D/E)No promoter pledge
Weak ROE
#293
View details ➜
B
Bandaram Pharma Packtech Ltd
Score 48/100• Risky
The stock presents several risks, particularly in growth consistency and valuation, making it a risky investment at this time.
Company’s Health72/100
Valuation 80/100 · PB 1.7697
Technical Avoid
1M -24.609% 6M -43.014% 1Y -52.397%
Confidence100%
No promoter pledgeReasonable PB valuation
Weak ROEThin margins
#294
View details ➜
B
Bafna Pharmaceuticals Ltd
Score 48/100• Decent
Bafna Pharmaceuticals has a decent outlook with growth potential, but faces challenges in profitability and market sentiment.
Company’s Health78/100
Valuation 40/100 · PB 4.006
Technical Avoid
1M -20.108% 6M 89.273% 1Y 82.816%
Confidence100%
Low leverage (D/E)No promoter pledge
Weak ROEThin margins
#295
View details ➜
A
Anondita Medicare Ltd
Score 48/100• Risky
Anondita Medicare Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment.
Company’s Health91/100
Valuation 20/100 · PB 27.5908
Technical Momentum
1M 58.036% 6M 105.946% 1Y 105.946%
Confidence100%
No promoter pledgeHealthy profit margins
#296
View details ➜
A
Amerise Biosciences Ltd
Score 48/100• Risky
Amerise Biosciences Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
Company’s Health50/100
Valuation 100/100 · PB 0.7982
Technical Avoid
1M -9.589% 6M -28.571% 1Y -19.753%
Confidence100%
Low leverage (D/E)No promoter pledge
Weak ROEThin margins
#297
View details ➜
A
Alpa Laboratories Ltd
Score 48/100• Risky
Alpa Laboratories Ltd presents a risky investment due to inconsistent growth and profitability metrics, alongside valuation concerns.
Company’s Health80/100
Valuation 80/100 · PB 1.1239
Technical Avoid
1M 3.347% 6M -11.261% 1Y -18.626%
Confidence100%
Low leverage (D/E)No promoter pledge
#298
View details ➜
A
Ajooni Biotech Ltd
Score 48/100• Risky
Ajooni Biotech Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment.
Company’s Health63/100
Valuation 80/100 · PB 1.011
Technical Avoid
1M -1.711% 6M -12.963% 1Y -33.633%
Confidence100%
Low leverage (D/E)No promoter pledge
Weak ROEThin margins
#299
View details ➜
A
Aarey Drugs and Pharmaceuticals Ltd
Score 48/100• Risky
Aarey Drugs and Pharmaceuticals Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
Company’s Health58/100
Valuation 80/100 · PB 1.9444
Technical Momentum
1M 14.696% 6M 78.649% 1Y 54.072%
Confidence100%
Low leverage (D/E)No promoter pledge
Weak ROEThin margins
#300
View details ➜
Showing 286 to 300 of 301 (21 Pages)